ResearcherCangzhou Central HospitalNo recent work listed

F Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2686-7126; OpenAlex author ID A5029913661. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway. Last author DOI 10.4149/neo_2019_190404n295 ↗
Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. First author PMID 23467940 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Z. Wang · 1 shared paper, 2020 · strength 0.13
- Paper Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deac… DOI 10.4149/neo_2019_190404n295 ↗
Xiyong Liu · 1 shared paper, 2013 · strength 0.05
- Paper Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. PMID 23467940 ↗
Peng Fu · 1 shared paper, 2013 · strength 0.05
- Paper Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. PMID 23467940 ↗
Haiyan Wei · 1 shared paper, 2013 · strength 0.05
- Paper Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. PMID 23467940 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.